申请人:Dietz Michel
公开号:US20080085905A1
公开(公告)日:2008-04-10
The present invention relates to compounds of the formula
wherein R
1
to R
4
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB
2
receptors.
本发明涉及以下式的化合物
其中R
1
到R
4
如描述和索赔中定义,并且其药学上可接受的盐。这些化合物对于治疗和/或预防与CB
2
受体调节相关的疾病是有用的。